 |
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
|
||||
| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
,
,¶
*Department of Internal Medicine, Kidney Epidemiology and Cost Center, Division of Nephrology, Department of Internal Medicine, and Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; and ¶ Division of Renal Diseases and Hypertension, University of Texas Health Sciences Center at Houston, Texas.
Correspondence to Austin G. Stack, Assistant Professor in Internal Medicine, Division of Renal Diseases and Hypertension, University of Texas Health Science Center at Houston, 6431 Fannin St, MSB 4.148, Houston, TX 77030. Phone: 713-500-6873; Fax: 713-500-6882;
ABSTRACT. It is unclear whether peritoneal dialysis (PD) compared with hemodialysis (HD) confers a survival advantage in end-stage renal disease (ESRD) patients with coronary artery disease (CAD). This hypothesis was tested in a national cohort of 107,922 patients starting dialysis therapy between May 1, 1995, and July 31, 1997. Data on patient characteristics were obtained from the Center for Medicare and Medicaid Services Medical Evidence Form (CMS) and linked to mortality data from the United States Renal Data System (USRDS). Patients were classified on the basis of CAD presence and followed until death or the end of 2 yr. Nonproportional Cox regression models estimated the relative risk (RR) of death for patients with and without CAD by dialysis modality using primarily the intent-to-treat but also the as-treated approach. Diabetic patients (DM) and nondiabetic patients (non-DM) were analyzed separately. Among DM, patients with CAD treated with PD had a 23% higher RR (95% CI, 1.12 to 1.34) compared with similar HD patients, whereas patients without CAD receiving PD had a 17% higher RR (CI, 1.08 to 1.26) compared with HD. Among non-DM, patients with CAD treated with PD had a 20% higher RR (CI. 1.10 to 1.32) compared with HD patients, whereas patients without CAD had similar survival on PD or HD (RR = 0.99; CI, 0.93 to 1.05). The mortality risk for new ESRD patients with CAD differed by treatment modality. In both DM and non-DM, patients with CAD treated with PD had significantly poorer survival compared with HD. Whether differences in solute clearance and/or cardiac risk profiles between PD and HD may explain these findings deserves further investigation. E-mail: Austin.Stack@uth.tmc.edu
This article has been cited by other articles:
 |
|
 |
|
  P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella Reimbursement and economic factors influencing dialysis modality choice around the world Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Panichi, G. M. Rizza, S. Paoletti, R. Bigazzi, M. Aloisi, G. Barsotti, P. Rindi, G. Donati, A. Antonelli, E. Panicucci, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2337 - 2343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Jassal MB BCh MD, L. Trpeski MPH MD, N. Zhu MD, S. Fenton MD, and B. Hemmelgarn PhD MD Changes in survival among elderly patients initiating dialysis from 1990 to 1999 Can. Med. Assoc. J., October 23, 2007; 177(9): 1033 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tanaka, N. Joki, and H. Hase History of acute coronary events during the predialysis phase of chronic kidney disease is a strong risk factor for major adverse cardiac events in patients initiating haemodialysis Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2917 - 2923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Mehrotra, D. Kermah, L. Fried, K. Kalantar-Zadeh, O. Khawar, K. Norris, and A. Nissenson Chronic Peritoneal Dialysis in the United States: Declining Utilization Despite Improving Outcomes J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2781 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tomson, U. Udayaraj, J. Gilg, and D. Ansell Comorbidities in UK patients at the start of renal replacement therapy (Chapter 6) Nephrol. Dial. Transplant., August 1, 2007; 22(suppl_7): vii58 - vii68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Garcia-Garcia, G. Briseno-Renteria, V. H. Luquin-Arellan, Z. Gao, J. Gill, and M. Tonelli Survival among Patients with Kidney Failure in Jalisco, Mexico J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1922 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Van Biesen, F. Verbeke, and R. Vanholder Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 53 - 58. [Full Text] [PDF]
|
|
|
|
|
|
L. Segall and A. Covic Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 59 - 63. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Saxena and C. West Peritoneal dialysis: a primary care perspective. J Am Board Fam Med, July 1, 2006; 19(4): 380 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Inrig, J. L. Sun, Q. Yang, L. P. Briley, and L. A. Szczech Mortality by Dialysis Modality among Patients Who Have End-Stage Renal Disease and Are Awaiting Renal Transplantation Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 774 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Boulware, Y. Liu, N. E. Fink, J. Coresh, D. E. Ford, M. J. Klag, and N. R. Powe Temporal Relation among Depression Symptoms, Cardiovascular Disease Events, and Mortality in End-Stage Renal Disease: Contribution of Reverse Causality Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 496 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Ayus, M. R. Mizani, S. G. Achinger, R. Thadhani, A. S. Go, and S. Lee Effects of Short Daily versus Conventional Hemodialysis on Left Ventricular Hypertrophy and Inflammatory Markers: A Prospective, Controlled Study J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2778 - 2788. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Ann Intern Med, August 2, 2005; 143(3): 174 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Parekh, L. Zhang, B. A. Fivush, and M. J. Klag Incidence of Atherosclerosis by Race in the Dialysis Morbidity and Mortality Study: A Sample of the US ESRD Population J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. V.R. Murthy, D. A. Molony, and A. G. Stack Survival Advantage of Hispanic Patients Initiating Dialysis in the United States Is Modified by Race J. Am. Soc. Nephrol., March 1, 2005; 16(3): 782 - 790. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Rayner, R. L. Pisoni, J. Bommer, B. Canaud, E. Hecking, F. Locatelli, L. Piera, J. L. Bragg-Gresham, H. I. Feldman, D. A. Goodkin, et al. Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol. Dial. Transplant., January 1, 2004; 19(1): 108 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Abbott, C. M. Yuan, A. J. Taylor, D. F. Cruess, and L. Y. C. Agodoa Early Renal Insufficiency and Hospitalized Heart Disease after Renal Transplantation in the Era of Modern Immunosuppression J. Am. Soc. Nephrol., September 1, 2003; 14(9): 2358 - 2365. [Abstract] [Full Text] [PDF]
|
|
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673
